Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship.

MLA

Bhatt, Nilesh B., et al. “Nevirapine or Efavirenz for Tuberculosis and HIV Coinfected Patients: Exposure and Virological Failure Relationship.” The Journal of Antimicrobial Chemotherapy, vol. 70, no. 1, Jan. 2015, pp. 225–32. EBSCOhost, https://doi.org/10.1093/jac/dku348.

APA

Bhatt, N. B., Baudin, E., Meggi, B., da Silva, C., Barrail-Tran, A., Furlan, V., Grinsztejn, B., Bonnet, M., & Taburet, A.-M. (2015). Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship. The Journal of Antimicrobial Chemotherapy, 70(1), 225–232. https://doi.org/10.1093/jac/dku348

Chicago

Bhatt, Nilesh B, Elisabeth Baudin, Bindiya Meggi, Carlota da Silva, Aurélie Barrail-Tran, Valérie Furlan, Beatriz Grinsztejn, Maryline Bonnet, and Anne-Marie Taburet. 2015. “Nevirapine or Efavirenz for Tuberculosis and HIV Coinfected Patients: Exposure and Virological Failure Relationship.” The Journal of Antimicrobial Chemotherapy 70 (1): 225–32. doi:10.1093/jac/dku348.